Fungal meningitis risk factors
|
Fungal meningitis Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Fungal meningitis risk factors On the Web |
|
American Roentgen Ray Society Images of Fungal meningitis risk factors |
|
Risk calculators and risk factors for Fungal meningitis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby; Prince Tano Djan, BSc, MBChB [2]
Overview
Fungal meningitis rarely occurs in otherwise healthy individuals. Co-existing medical conditions, immunosuppression and travel history to areas where specific fungi are endemic are risk factors for fungal meningitis. [1][2][3][4][5][6][7][8]
Risk Factors
Risk factors in the development of fungal meningitis include:[9][10][1][2][3][4][5][6][7][8][11]
- Aspergillus sp.
- Blastomyces dermatitidis
- Travel to or residence in midwestern and southeastern USA
- Systemic infection
- Abscesses
- Draining sinus
- Ulcers
- Coccidioides immitis
- Candida sp.
- IV drug abuse
- Post surgery
- Prolonged intravenous therapy
- Disseminated candidiasis
- Cryptococcus neoformans
- Human immunodeficiency virus (HIV) / acquired immunodeficiency syndrome (AIDS)
- Immune suppression examples systemic neoplasia and organ transplantation
- Pigeon exposure
- Skin and other organ involvement due to disseminated infection
- Histoplasma capsulatum
- Exposure history
- Travel to or residence in Ohio and central Mississippi River Valley
- Human immunodeficiency virus (HIV) / acquired immunodeficiency syndrome (AIDS)
- Mucosal lesions
- Pseudoallescheria boydii
- Water aspiration
- Sporothrix schenckii
- Traumatic inoculation
- IV drug use
- Ulcerated skin lesion[12]
References
- ↑ 1.0 1.1 Chiller TM, Galgiani JN, Stevens DA (2003). "Coccidioidomycosis". Infect Dis Clin North Am. 17 (1): 41–57, viii. PMID 12751260.
- ↑ 2.0 2.1 Singh N, Husain S (2000). "Infections of the central nervous system in transplant recipients". Transpl Infect Dis. 2 (3): 101–11. PMID 11429020.
- ↑ 3.0 3.1 Rosenstein NE, Emery KW, Werner SB, Kao A, Johnson R, Rogers D; et al. (2001). "Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996". Clin Infect Dis. 32 (5): 708–15. doi:10.1086/319203. PMID 11229838.
- ↑ 4.0 4.1 Gottfredsson M, Perfect JR (2000). "Fungal meningitis". Semin Neurol. 20 (3): 307–22. doi:10.1055/s-2000-9394. PMID 11051295.
- ↑ 5.0 5.1 Fraser DW, Ward JI, Ajello L, Plikaytis BD (1979). "Aspergillosis and other systemic mycoses. The growing problem". JAMA. 242 (15): 1631–5. PMID 480580.
- ↑ 6.0 6.1 Perfect JR, Lang SD, Durack DT (1980). "Chronic cryptococcal meningitis: a new experimental model in rabbits". Am J Pathol. 101 (1): 177–94. PMC 1903580. PMID 7004196.
- ↑ 7.0 7.1 Perfect JR, Durack DT (1985). "Chemotactic activity of cerebrospinal fluid in experimental cryptococcal meningitis". Sabouraudia. 23 (1): 37–45. PMID 3992427.
- ↑ 8.0 8.1 Perfect JR, Durack DT (1985). "Effects of cyclosporine in experimental cryptococcal meningitis". Infect Immun. 50 (1): 22–6. PMC 262129. PMID 3899932.
- ↑ Morgand M, Rammaert B, Poirée S, Bougnoux ME, Tran H, Kania R; et al. (2015). "Chronic Invasive Aspergillus Sinusitis and Otitis with Meningeal Extension Successfully Treated with Voriconazole". Antimicrob Agents Chemother. 59 (12): 7857–61. doi:10.1128/AAC.01506-15. PMC 4649149. PMID 26392507.
- ↑ Shankar SK, Mahadevan A, Sundaram C, Sarkar C, Chacko G, Lanjewar DN; et al. (2007). "Pathobiology of fungal infections of the central nervous system with special reference to the Indian scenario". Neurol India. 55 (3): 198–215. PMID 17921648.
- ↑ Mody CH, Toews GB, Lipscomb MF (1988). "Cyclosporin A inhibits the growth of Cryptococcus neoformans in a murine model". Infect Immun. 56 (1): 7–12. PMC 259224. PMID 3275587.
- ↑ Koroshetz WJ. Chapter 382. Chronic and Recurrent Meningitis. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, eds. Harrison's Principles of Internal Medicine. 18th ed. New York: McGraw-Hill; 2012.